Latest Moderna News & Updates

See the latest news and media coverage for Moderna. We track all announcements, press releases, and industry mentions in real time, all in one place.

Moderna

Developer of mRNA therapeutics and vaccines

modernatx.com

Headquarters: Cambridge, United States
Founded year: 2010
Company type: Public company
Number of employees: 1,000–6,500
Industry: Pharmaceuticals

Last updated Today

Latest news about Moderna

In short: Moderna advanced its clinical pipeline and international growth while managing diverse patent litigation and evolving regulatory reviews.

Company announcements

July 31 Moderna

Moderna reported Q2 2026 financial results and business updates

CEO Stéphane Bancel, President Stephen Hoge, and CFO Jamey Mock discussed performance, cost discipline, and late-stage pipeline milestones.

June 25 Moderna

Moderna outlines three horizons for future growth

CEO Stéphane Bancel details plans for near-term growth, new modalities, and AI-driven innovation to achieve cash breakeven by 2028.

June 1 Moderna

Moderna presented 5-year melanoma data at ASCO 2026

The combination of intismeran autogene and KEYTRUDA showed sustained improvement in relapse-free survival and distant metastasis-free survival compared with KEYTRUDA alone.

May 6 Moderna

Moderna announces Phase 3 results publication for mRNA-1010 influenza vaccine

The New England Journal of Medicine publishes safety and efficacy data from study P304 in adults aged 50+.

Media coverage

Yesterday NPR

FDA weighs a new kind of flu shot based on technology RFK Jr. has questioned

The FDA is poised to render a decision on Moderna's mRNA-based flu shot, which could be the first of...

July 31 MSN

Moderna burns cash, suffers fresh vaccine setback

Moderna Inc. MRNA on Friday reported a second-quarter loss of $1.97 per share, beating the consensus loss of $2.10 per share. The COVID-19 vaccine maker...

July 31 MSN

Moderna adds new cohort to Phase III vaccine trial after interim data miss

The Phase III trial on mRNA-1403 will continue blinded as Moderna enrols the new cohort.

July 31 GuruFocus

Moderna (MRNA) Shares Drop After Q2 Earnings and Forecast Cut

On July 31, 2026, Moderna Inc (MRNA) shares fell over 2% in pre-market trading following the release...

Never miss news about Moderna

Track Moderna and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Moderna competitors & trending companies

Browse news for competitors to Moderna and other trending companies.